Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) and Peripheral Blood Stem Cells (PBSC) After a High Dose Melphalan Conditioning Regimen, With Administration of Interleukin-2, in Patients With Multiple Myeloma

Investigator(s):
Sarah Larson, M.D.
Organization: 
UCLA
NCT Number: 
Disease Name: 
Multiple Myeloma
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Closed
Antoni Ribas, M.D., Ph.D.
Trial Contact: 

Ignacio Baselga Carretero, Ph.D.
(310) 206-2090
IBaselga@mednet.ucla.edu